Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;95(1):e28118.
doi: 10.1002/jmv.28118. Epub 2022 Sep 20.

Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review

Affiliations

Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review

Chao Wang et al. J Med Virol. 2023 Jan.

Abstract

We aim to evaluate the evolution differences in the incidence and case fatality rate (CFR) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants. The average incidence and CFRs were described between different countries. A gamma generalized linear mixed model (GLMM) was used to compare the CFRs of Delta and Omicron variants based on vaccination coverage. Totally, 50 countries were included for analyses. The incidence of coronavirus disease 2019 (COVID-19) ranged from 0.16/100,000 to 82.95/100,000 during the Delta period and 0.03/100,000 to 440.88/100,000 during the Omicron period. The median CFRs were 8.56 (interquartile range [IQR]: 4.76-18.39) during the Delta period and 3.04 (IQR: 1.87-7.48) during the Omicron period, respectively. A total of 47 out of 50 countries showed decreased CFRs of the Omicron variant with the rate ratio ranging from 0.02 (95% confidence interval [CI]: 0.01-0.03) (in Cambodia) to 0.97 (95% CI: 0.87-1.08) (in Ireland). Gamma GLMM analysis showed that the decreased CFR was largely a result of the decreased pathogenicity of Omicron besides the increased vaccination coverage. The Omicron variant shows a higher incidence but a lower CFR around the world as a whole, which is mainly a result of the decreased pathogenicity by SARS-CoV-2's mutation, while the vaccination against SARS-CoV-2 still acts as a valuable measure in preventing people from death.

Keywords: SARS-CoV-2 Delta; SARS-CoV-2 Omicron; case fatality rate.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The flow chart of the recruitment of countries for analysis
Figure 2
Figure 2
The time interval of Delta and Omicron periods that were extracted for data analysis. (A) The Delta period among 50 recruited countries. (B) The Omicron period among 50 recruited countries.
Figure 3
Figure 3
The incidences, case fatality rates, and rate ratios between Delta and Omicron periods among the 50 countries distributed around the world. (A) The incidences and case fatality rates during the Delta period among the 50 countries distributed around the world. (B) The incidences and case fatality rates during the Omicron period among the 50 countries distributed around the world. (C) Rate ratios of the incidences between Delta and Omicron periods among the 50 countries distributed around the world. (D) Rate ratios of the case fatality rates (CFRs) between Delta and Omicron periods among the 50 countries distributed around the world.
Figure 4
Figure 4
The forest plot of the pooled analysis on rate ratios of the incidences and case fatality rates between Delta and Omicron periods categorized by population size, gross domestic product (GDP) per capita, vaccination coverages, and area. (A) The pooled‐analysis on rate ratios of the incidences and case fatality categorized by population size. (B) The pooled‐analysis on rate ratios of the incidences and case fatality categorized by GDP per capita. (C) The pooled‐analysis on rate ratios of the incidences and case fatality categorized by vaccination coverages. (D) The pooled‐analysis on rate ratios of the incidences and case fatality categorized by area.
Figure 5
Figure 5
Impacts of vaccination on the incidence and case fatality between Delta and Omicron periods among the 50 countries. (A) Impacts of partial vaccination coverages on the incidence and case fatality between Delta and Omicron periods. (B) Impacts of fully vaccination coverages on the incidence and case fatality between Delta and Omicron periods. (C) Impacts of booster vaccination coverages on the incidence and case fatality between Delta and Omicron periods.

Comment in

References

    1. WHO . WHO Coronavirus (COVID‐19) Dashboard. 2022. Accessed July 20, 2022. https://WHOCoronavirus(COVID-19)Dashboard
    1. Jin Y, Yang H, Ji W, et al. Virology, epidemiology, pathogenesis, and control of COVID‐19. Viruses. 2020;12(4):372. - PMC - PubMed
    1. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID‐19. Lancet. 2020;395(10229):1014‐1015. - PMC - PubMed
    1. Odusanya OO, Odugbemi BA, Odugbemi TO, Ajisegiri WS. COVID‐19: a review of the effectiveness of non‐pharmacological interventions. Niger Postgrad Med J. 2020;27(4):261‐267. - PubMed
    1. Saban M, Myers V, Wilf‐Miron R. Changes in infectivity, severity and vaccine effectiveness against delta COVID‐19 variant ten months into the vaccination program: the Israeli case. Prev Med. 2022;154:106890. - PMC - PubMed

Publication types

Supplementary concepts